UBTECH Robotics to Acquire Control of Zhejiang Fenglong Electric for 1.665 Billion Yuan, Accelerating Humanoid Robot Development and Commercialization

Stock News2025-12-28

Major Developments: MicroPort MedBot (02252): The global commercial installation base for its Toumai robot has surpassed 100 units. Changfeng Pharmaceutical (02652): The company's leading novel inhaled nucleic acid drug development project was selected for the 2025 Jiangsu Provincial Major Science and Technology Project "Innovative Biologics." BioMap (02315) has been added to the Hong Kong Stock Connect list of securities. UBTECH ROBOTICS (09880) plans to acquire a controlling stake in Zhejiang Fenglong Electric Co.,Ltd. (002931.SZ) for 1.665 billion yuan to accelerate the development and commercialization of humanoid robots.

China Aluminum International Engineering (02068) has signed a project contract with an overseas client, with a total contract value of approximately 14 billion yuan. CNGR Advanced Material (02579) has signed a strategic cooperation framework agreement with Sunwoda for solid-state batteries. Huadian Power International (01071): Both 660 MW ultra-supercritical units of the Huadian Longkou Phase IV project have been fully completed and are now operational.

Sinohealth Holdings (02361) has made significant progress in the commercial application of its AI large model and AI agents, successfully transitioning into an AI technology service provider. Hengxin Technology (01085): Its Zhangyu 200MW/400MWh independent energy storage project has received approval for grid connection to Hainan Power Grid. Alpine Enterprises (00616) has entered into a memorandum of understanding to establish a joint venture, which will participate in or invest in stablecoin and blockchain-related industries.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment